Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120102 Administered Intrathecally in Patients With Huntington's Disease

Next Previous
X
Search
Trial Profile

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120102 Administered Intrathecally in Patients With Huntington's Disease

Status: Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 27 Apr 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lexanersen (Primary)
  • Indications Huntington's disease
  • Focus Adverse reactions; First in man
  • Acronyms PRECISION-HD2
  • Sponsors WaVe life Sciences

    • Most Recent Events

    • 02 Apr 2022 This trial has been completed in France (Date of the global end of the trial : 10-May-2021), according to European Clinical Trials Database record.
    • 16 Jun 2021 Status changed from active, no longer recruiting to discontinued due to lack of efficacy.
    • 21 May 2021 This trial has been discontinued in Denmark, according to European Clinical Trials Database record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top